# Bone Marrow Transplantation in Treating Children With Sickle Cell Disease

> **NCT00004485** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 50 (—)

## Conditions studied

- Sickle Cell Anemia

## Interventions

- **DRUG:** cyclosporine
- **DRUG:** fludarabine
- **DRUG:** mycophenolate mofetil
- **PROCEDURE:** Bone Marrow Transplantation

## Key facts

- **NCT ID:** NCT00004485
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** 2007-08
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2008-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004485, "Bone Marrow Transplantation in Treating Children With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00004485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*